Resectable Non-small Cell Lung Cancer
13 clinical trials · Condition
◉ Watch Resectable Non-small Cell Lung Cancer
| Record | Firm | Date |
|---|---|---|
| AK112 Neoadjuvant/Adjuvant Treatment for Resectable NSCLC (NCT05247684) | Akeso | 2022-02-20 |
| Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) (NCT04198766) | Inhibrx Biosciences, Inc | 2019-12-10 |
| Mechanism of Action Trial of ColoAd1 (NCT02053220) | Akamis Bio | 2013-06-01 |
Track Resectable Non-small Cell Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.